Finance

Beta
Lists
AVXL:NASDAQ
Anavex Life Sciences Corp
2,73 USD
+2,25%
(+0,060) 1D
2,75 USD
+0,73% (+0,020)
After hours
Closed: 18-июн., 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AVXL...
Open
2,73 USD
High
2,78 USD
Low
2,58 USD
Mkt. cap
252,99 млн
Avg. vol.
1,15 млн
Volume
8,91 млн
52-wk high
13,99 USD
52-wk low
2,41 USD
EPS
-0,46 USD
Beta
1,20
Shares outstanding
92,67 млн
No. of employees
34
Open
2,73 USD
High
2,78 USD
Low
2,58 USD
Mkt. cap
252,99 млн
Avg. vol.
1,15 млн
Volume
8,91 млн
52-wk high
13,99 USD
52-wk low
2,41 USD
EPS
-0,46 USD
Beta
1,20
Shares outstanding
92,67 млн
No. of employees
34
Analyst outlook
Analyst Ratings
Based on 2 analysts giving stock ratings to AVXL in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12 month forecast
Based on 2 Wall Street analysts offering 12 month price targets for AVXL in the last 3 months.
Highest
Current 2,73 USD
20,00 USD (+632,60%)
Average
20,00 USD (+632,60%)
Lowest
20,00 USD (+632,60%)
News stories
From sources across the web
About Anavex Life Sciences Corp
CEOChristopher U. Missling Ph.D.
Employees34
Founded2004
HeadquartersНью-Йорк, Нью Йорк, Америка Кошмо Штаттары
Sector-
Websiteanavex.com
Awaiting results...
Call Time: 16-июн., шейш., 14:30
Fiscal period
Q2 2026
EPS / Est. (USD)
- / -0,07 USD
Revenue / Est. (USD)
- / 0,00
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
2025-ж. мар.
2025-ж. июн.
2025-ж. сен.
2025-ж. дек.
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
9,80 млн
9,83 млн
7,15 млн
4,62 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2,62 млн
4,50 млн
3,68 млн
2,13 млн
Operating expense
12,42 млн
14,33 млн
10,83 млн
6,75 млн
Total operating expenses
12,42 млн
14,33 млн
10,83 млн
6,75 млн
Operating income
-12,42 млн
-14,33 млн
-10,83 млн
-6,75 млн
Other non operating income
-
25,00 миң
-
-
EBT including unusual items
-11,20 млн
-13,24 млн
-9,83 млн
-5,66 млн
EBT excluding unusual items
-11,20 млн
-13,24 млн
-9,83 млн
-5,66 млн
Income tax expense
-
-
-
18,00 миң
Effective tax rate
-
-
-
-0,32%
Other operating expenses
-
-
-
-
Net income
-11,20 млн
-13,24 млн
-9,83 млн
-5,68 млн
Net profit margin
-
-
-
-
Earnings per share
-0,13
-0,16
-0,11
-0,06
Interest and investment income
1,21 млн
1,08 млн
999,00 миң
1,08 млн
Interest expense
-
-
-
-
Net interest expenses
1,21 млн
1,08 млн
999,00 миң
1,08 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer